Notice ID: 4f78d67201a44af7af9c2f484841f533Award NoticeAwarded
6505--Cefuroxime Tablets (VA-26-00005794)
Awarded on December 18, 2025. Award Notice posted by VETERANS AFFAIRS, DEPARTMENT OF on December 18, 2025. Solicitation 36E79725R0059.
NAICS 325412 (Pharmaceutical Preparation Manufacturing). Full description on SAM.gov.
Awarded tounder 36E79726D0008 (source: SAM.gov award notice)• $940.4K
Description
Overview
Agency:
Department of Veterans Affairs
Office:NAC PHARMACEUTICALS (36E797)
Posted:December 18, 2025
NAICS:325412: Pharmaceutical Preparation Manufacturing
Last Updated:Aug 21, 2026
PSC:6505: DRUGS AND BIOLOGICALS
Response Deadline:
Not specified
Set-Aside:Not specified
Type:Award Notice
Place of Performance:Not specified
Award Date:Dec 18, 2025
Award Amount (SAM.gov award notice):$940.4K
Award Overview
Award Number
36E79726D0008
Award Amount (SAM.gov award notice)
$940.4K
Award Date
Dec 18, 2025
Awardee
Awardee UEI
MV3FLB6ATM27
Awardee CAGE Code
5DH24
Original Solicitation
Notice ID: 4f78d67201a44af7af9c2f484841f533
Posted Date: Dec 18, 2025
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Documents
Select documents to download
Showing 2 of 2 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Solicitation | VETERANS AFFAIRS, DEPARTMENT OF | Dec 18, 2025 | 303.49 KB | |||
| Award Notice | VETERANS AFFAIRS, DEPARTMENT OF | Dec 18, 2025 | 13.35 KB |
Lifecycle
Solicitation:
36E79725R0059- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationSep 8, 2025
6505--Cefuroxime Tablets (VA-26-00005794)
- SolicitationSep 24, 2025
6505--Cefuroxime Tablets (VA-26-00005794)
- AwardedCurrentDec 18, 2025
6505--Cefuroxime Tablets (VA-26-00005794)
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
VA Federal Supply Schedule Greetings Industry, The Department of Veterans Affairs, Enterprise Procurement Office, Office of Acquisition, Logistics, and Construction, in collaboration with the Coalition for Common Sense in Government Procurement, will host a Pharmaceutical Industry Day on November 20, 2026. This one day, in-person event is designed to bring together leaders from both Government and Industry to discuss current developments, challenges, and opportunities within the pharmaceutical sector as they relate to federal procurement. Discussion topics will include updates on policy changes, emerging procurement priorities, and strategies to strengthen collaboration between the VA and its pharmaceutical partners. This event supports ongoing efforts to enhance transparency, communication, and efficiency in the acquisition of pharmaceutical products for our nation s Veterans. Due to limited capacity, registration is limited to two (2) representatives per company and will be approved on a first-come, first-served basis. In advance of this event, all questions pertaining to the subject matter can be submitted to Ms. Regina McGregor, Director of Business Development & Small Business Technical Advisor, EPO, at Regina.McGregor@va.gov. To register to attend, click here: https://www.eventbrite.com/e/va-pharmaceutical-industry-day-tickets-2003087466534?aff=oddtdtcreator&keep_tld=true Thank you, Federal Supply Schedule Services Acquisition Service 5 Enterprise Procurement Office, P.O. Box 76, 1st Avenue, One Block North of 22nd Street, Hines, IL 60141 | Special Notice | 325412 | No Set-Aside | 10/13/2026 | 11/20/2026 | - | |
PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79726R0036 for an unrestricted procurement for Imatinib Mesylate Tablet, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. All unit of use packaging identified in the Schedule of Supplies, (Line items 1 - 2, 30 and 90 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Solicitation # 36E79726R0036 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 16, 2026, with a tentative closing date of October 30, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Andrew Cazares. Questions can be e-mailed to Andrew.Cazares@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 Imatinib Mesylate 100MG Tablet 90 6,397 2 Imatinib Mesylate 400MG Tablet 30 23,212 | Pre-Solicitation | 325412 | No Set-Aside | 10/05/2026 | 10/16/2026 | - | |
PRE-SOLICITATION NOTICE: The VA Enterprise Procurement Office intends to issue Request for Proposal (RFP) 36E79727R0039 for an unrestricted procurement for Latanoprost Ophthalmic Solution, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD) (inclusive of Tricare Mail Order Pharmacies (TMOPs)), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. One or more of the items under this acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere on top of the successful offeror/contractor s label. The vendor must follow the American Academy of Ophthalmology s recommended uniform color-coding system for the caps and labels of all topical ocular medications. https://www.aao.org/about/policies/color-codes-topical-ocular-medications Solicitation # 36E79727R0039 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 21, 2026, with a tentative closing date of November 4, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Sullivan. Questions can be e-mailed to james.sullivan3@va.gov. The estimated annual requirements are as follows: | Pre-Solicitation | 325412 | No Set-Aside | 10/02/2026 | 10/16/2026 | - | |
| Solicitation | 325412 | No Set-Aside | 09/30/2026 | 10/14/2026 | - | ||
| Awarded | 325412 | No Set-Aside | 09/29/2026 | Open | - |
Additional Details
Solicitation Number
36E79725R0059
Archive Date
Mar 27, 2026
Office Address
HINES, IL, 60141